Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Currently established and employed biomarkers of Alzheimer's disease (AD) predominantly mirror AD-associated molecular and structural brain changes. While they are necessary for identifying disease-specific neuropathology, they lack a clear and robust relationship with the clinical presentation of dementia; they can be altered in healthy individuals, while they often inadequately mirror the degree of cognitive and functional deficits in affected subjects. There is growing evidence that synaptic loss and dysfunction are early events during the trajectory of AD pathogenesis that best correlate with the clinical symptoms, suggesting measures of brain functional deficits as candidate early markers of AD. Resting-state electroencephalography (EEG) is a widely available and noninvasive diagnostic method that provides direct insight into brain synaptic activity in real time. Quantitative EEG (qEEG) analysis additionally provides information on physiologically meaningful frequency components, dynamic alterations and topography of EEG signal generators, i.e. neuronal signaling. Numerous studies have shown that qEEG measures can detect disruptions in activity, topographical distribution and synchronization of neuronal (synaptic) activity such as generalized EEG slowing, reduced global synchronization and anteriorization of neuronal generators of fast-frequency resting-state EEG activity in patients along the AD continuum. Moreover, qEEG measures appear to correlate well with surrogate markers of AD neuropathology and discriminate between different types of dementia, making them promising low-cost and noninvasive markers of AD. Future large-scale longitudinal clinical studies are needed to elucidate the diagnostic and prognostic potential of qEEG measures as early functional markers of AD on an individual subject level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Cognitive reserve in ageing and Alzheimer's disease
Stern, Y. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70191-6 · Cited by 3,557
Jessen, F., Amariglio, R. E., van Boxtel, M., Breteler, M., Ceccaldi, M., Chételat, G., Dubois, B., Dufouil, C., Ellis, K. A., van der Flier, W. M., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.01.001 · Cited by 3,014
Pascual-Marqui, R. D., Michel, C. M., & Lehmann, D. (1994) · International Journal of Psychophysiology · doi:10.1016/0167-8760(84)90014-x · Cited by 2,869
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863
Cited by
Tzimourta, K. D., Christou, V., Tzallas, A. T., Giannakeas, N., Astrakas, L. G., Angelidis, P., Tsalikakis, D., & Tsipouras, M. G. (2021) · International Journal of Neural Systems · doi:10.1142/s0129065721300023 · Cited by 78
EEG p-adic quantum potential accurately identifies depression, schizophrenia and cognitive decline
Shor, O., Glik, A., Yaniv-Rosenfeld, A., Valevski, A., Weizman, A., Khrennikov, A., & Benninger, F. (2021) · PLOS ONE · doi:10.1371/journal.pone.0255529 · Cited by 38
“Electroencephalography (EEG) is an inexpensive and well-established tool [7, 8] used for resting-state power, spectral and functional connectivity analyses as well as microstate analysis, which may assist in diagnosing these disorders [9–14] with variable success and little use in clinical practice.”
MethodMoral-Rubio, C., Balugo, P., Fraile-Pereda, A., Pytel, V., Fernández-Romero, L., Delgado-Alonso, C., Delgado-Álvarez, A., Matias-Guiu, J., Matias-Guiu, J. A., & Ayala, J. L. (2021) · Brain Sciences · doi:10.3390/brainsci11101262 · Cited by 25
Jiang, Y., Guo, Z., Zhou, X., Jiang, N., & He, J. (2025) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-025-01594-z · Cited by 7
Di Caro, V., Cho, E., North, H. A., Caldwell, J., Pandey, K., Duong, D., Grundman, M., de Haan, W., Vijverberg, E. G., Teunissen, C. E., et al. (2025) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.70119 · Cited by 2
Metadata
- Authors
- Smailovic, U., & Jelic, V.
- Venue
- Neurology and Therapy
- Published
- 2019-12
- Volume
- 8
- Issue
- S2
- Pages
- 37-55
- ISSN
- 2193-6536 (ISSN-L)
- 2193-8253
- OpenAlex
- W2996150132
- Cited by
- 136
- References
- 29
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach. https://app.cochat.ai/papers/10.1007/s40120-019-00169-0
- The paper
- Smailovic, U., & Jelic, V. (2019). Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach. Neurology and Therapy. https://doi.org/10.1007/s40120-019-00169-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.